Goodnow joins Garvan as deputy director
Professor Chris Goodnow has joined the Garvan Institute of Medical Research as deputy director. He has also accepted The Bill and Patricia Ritchie Foundation Chair.
At Garvan he will head the Immunogenomics Group to investigate the underlying genetic causes of immune disorders, particularly autoimmune diseases.
Goodnow, who is current president of the Australasian Society for Immunology, leaves the Division of Immunology at the John Curtin School of Medical Research, Australian National University (ANU). He joined ANU in 1997 as Professor and director of the Medical Genome Centre, leading its development into a Major National Research Facility, the Australian Phenomics Facility.
While at Garvan, Goodnow will continue to pursue his interest in how the immune system makes its decisions, in particular how it distinguishes between ‘self’ and ‘non-self’.
He will take full advantage of the powerful whole genome sequencers at The Kinghorn Cancer Centre as well as in-house capacity to engineer mice with specific genetic mutations.
At the same time, he hopes to establish a network of people working in the field of autoimmunity to combine clinical expertise with genomic and molecular immunology research.
Shingles vaccine may reduce risk of heart attack and stroke
Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...
Perioperative trial offers insights into brain cancer treatment
Victorian brain cancer researchers have used an innovative process to learn how a new drug...
New molecular mechanism found for depression
Depression may not only result from simple neuronal damage but can also arise from the...